Cargando…
Anticoagulation is the answer in treating noncritical COVID-19 patients
All autopsy studies demonstrated widespread thrombosis and alveolar-capillary microthrombi as the cause of death among patients with COVID-19. The autopsy studies are the gold-standard for diagnostic accuracy and therapeutic strategies for any clinical scenarios. The author initially observed that p...
Autor principal: | Kabir, Azad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494147/ https://www.ncbi.nlm.nih.gov/pubmed/34703901 http://dx.doi.org/10.1515/med-2021-0354 |
Ejemplares similares
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Publicado: (2021) -
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
por: Stone, Gregg W., et al.
Publicado: (2023) -
EVALUATION OF THERAPEUTIC VS PROPHYLACTIC ANTICOAGULATION IN NONCRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: GHOSH, KULDEEP, et al.
Publicado: (2022) -
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022) -
Telehealth for Noncritical Patients With Chronic Diseases During the COVID-19 Pandemic
por: Liu, Na, et al.
Publicado: (2020)